Chemours's Former Financial Chief to Depart Without Severance
By Ben Glickman Former Chemours Finance Chief Jonathan Lock is officially leaving the company without any severance compensation months after being placed on leave amid an accounting probe. The comp
WSJApr 25 18:10 ET
UPDATE 1-Chemours CFO Jonathan Lock Steps Down After Financial Revisions
Yahoo FinanceApr 25 18:05 ET
Express News | Chemours Co - Lock Will Not Be Entitled to a 2023 or 2024 Annual Cash Incentive Award
ReutersApr 25 17:48 ET
Express News | Chemours Co - on April 23, 2024, Jonathan S. Lock Resigned From All Positions
ReutersApr 25 17:26 ET
Express News | NYSE Order Imbalance 71495.0 Shares on Buy Side
ReutersApr 25 15:50 ET
Chemours Announces Dates for First Quarter 2024 Earnings Release and Webcast Conference Call
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2024 financial results after market close on Tuesday, April 30, 2024. The Company
BusinesswireApr 24 16:15 ET
Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on lower revenues when Chemours (CC) reports results for the quarter ended March 2024.
Yahoo FinanceApr 18 10:01 ET
Express News | NYSE Order Imbalance 63316.0 Shares on Sell Side
Moomoo 24/7Apr 17 15:50 ET
Wall Street's Most Accurate Analysts' Views On 3 Materials Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a hig
BenzingaApr 16 07:48 ET
ONGOING INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates The Chemours Company's Directors and Officers for Breach of Fiduciary Duties - CC
New York, New York--(Newsfile Corp. - April 12, 2024) - Scott+Scott Attorneys at Law LLP ("Scott+Scott"), an international securities and consumer rights litigation firm, is investigating whether cert
newsfileApr 12 16:00 ET
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates The Chemours Company's Directors and Officers for Breach of Fiduciary Duties - CC
New York, New York--(Newsfile Corp. - April 9, 2024) - Scott+Scott Attorneys at Law LLP ("Scott+Scott"), an international securities and consumer rights litigation firm, is investigating whether certa
newsfileApr 9 16:00 ET
Chemours Recognized for Sustainability Achievements at the U.S. Department of Energy Better Buildings, Better Plants Summit
NORTHAMPTON, MA / ACCESSWIRE / April 9, 2024 / The Chemours CompanyLast week, at the U.S. Department of Energy's (DOE) annual Better Buildings, Better Plants Summit in Washington, D.C., Chemours' repr
AccesswireApr 9 13:35 ET
Why Chemours Gets A Double Upgrade From This Analyst
Chemours Co (NYSE:CC) reported in late March its fourth-quarter earnings ahead of expectations. With the company's accounting issue in the rearview mirror, many of its businesses seem to be at or near
BenzingaApr 9 12:56 ET
Express News | Chemours Shares Are Trading Higher After BMO Capital Upgraded the Stock From Market Perform to Outperform and Raised Its Price Target From $19 to $34
Moomoo 24/7Apr 9 08:13 ET
Chemours Upgraded at BMO Capital After Internal Audit Completed
Seeking AlphaApr 9 07:40 ET
Chemours Raised to Outperform From Market Perform by BMO Capital
Chemours Raised to Outperform From Market Perform by BMO Capital
Dow JonesApr 9 05:58 ET
Express News | BMO Capital Upgrades Chemours to Outperform, Raises Price Target to $34
Moomoo 24/7Apr 9 05:48 ET
Peering Into Chemours's Recent Short Interest
Chemours's (NYSE:CC) short percent of float has risen 3.53% since its last report. The company recently reported that it has 4.88 million shares sold short, which is 4.4% of all regular shares that ar
BenzingaApr 4 09:00 ET
Chemours Is Maintained at Neutral by UBS
Chemours Is Maintained at Neutral by UBS
Dow JonesApr 2 16:17 ET
Peeling Back The Layers: Exploring Chemours Through Analyst Insights
Ratings for Chemours (NYSE:CC) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The following table provides a quick overview of their recent
BenzingaApr 2 16:01 ET
No Data
No Data